Company Filing History:
1 out of 2 
1 out of 80 
Years Active: 1992-2002
Title: Robin Fredric Anders: Innovator in Malaria Vaccine Development
Introduction
Robin Fredric Anders is a notable inventor based in North Melbourne, Australia. He has made significant contributions to the field of immunology, particularly in the development of vaccines against malaria. With a total of 2 patents, his work focuses on innovative approaches to combat Plasmodium infections.
Latest Patents
Anders' latest patents include a malaria merozoite antigen subunit vaccine. This immunogenic polypeptide is designed to induce an immune response against Plasmodium infection. It comprises an amino acid sequence corresponding to a non-full length fragment of the apical membrane antigen 1 (AMA-1) of Plasmodium species, excluding the transmembrane domain. The production of this immunogenic polypeptide involves the expression of a recombinant DNA molecule in a host cell, along with methods and compositions utilizing the polypeptide. Another significant patent involves the RESA and FIRA antigens of Plasmodium falciparum. This patent includes DNA molecules with polynucleotide sequences that correspond to the base sequence coding for antigens of Plasmodium falciparum, including the RESA and FIRA antigens. These DNA molecules can be expressed as polypeptides, and the patent also covers synthetic peptides or polypeptides that display the antigenicity of these antigens.
Career Highlights
Throughout his career, Robin Fredric Anders has worked with esteemed organizations such as Saramane Pty., Ltd. and the Walter and Eliza Hall Institute of Medical Research. His work in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Anders has collaborated with notable colleagues, including Pauline Elizabeth Crewther and Mary Shu Mai Leet. These partnerships have further enriched his research endeavors and have played a role in the development of his innovative solutions.
Conclusion
Robin Fredric Anders stands out as a key figure in the fight against malaria through his innovative vaccine research. His contributions to the field are marked by his patents and collaborations, showcasing his commitment to advancing medical science.